Index of reports
> Cases with Abdominal Pain (8)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Provera (Medroxyprogesterone) where reactions include abdominal pain. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Provera side effects in
Reported by a physician from United States on 2012-07-19
Patient:
Reactions: Abdominal Pain, Lymphadenopathy, Glossodynia, Osteomyelitis, Chronic Obstructive Pulmonary Disease, Colonic Polyp, Abdominal Discomfort, Oral Candidiasis, Pharyngeal Ulceration, Cellulitis, Peptic Ulcer, Oral Infection, Rectal Adenoma, Fungal Infection, Insomnia, Fistula Discharge, Tooth Abscess, Abdominal Pain Upper, Colitis Microscopic, Chest Pain, Blood Cholesterol Increased, Gastrooesophageal Reflux Disease, Drug Hypersensitivity, Haemorrhoids, Dental Caries, Musculoskeletal Pain, Appendix Disorder, Hyperlipidaemia, Anxiety, Osteonecrosis of JAW, Diarrhoea, Sepsis, Hypertension
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Actonel
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2008-04-20
End date: 2010-01-01
Fosamax
Dosage: 70 mg, qw
Administration route: Oral
Start date: 2008-02-12
End date: 2008-03-01
Fosamax
Dosage: 70 mg, qw
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2001-01-29
End date: 2008-03-20
Provera
Administration route: Oral
Start date: 2001-01-01
Possible Provera side effects in 58 year old female
Reported by a physician from United States on 2012-05-25
Patient: 58 year old female, weighing 66.0 kg (145.2 pounds)
Reactions: Abdominal Pain, Lymphadenopathy, Glossodynia, Osteomyelitis, Chronic Obstructive Pulmonary Disease, Abdominal Discomfort, Colonic Polyp, Oral Candidiasis, Pharyngeal Ulceration, Cellulitis, Peptic Ulcer, Oral Infection, Rectal Adenoma, Fungal Infection, Insomnia, Fistula Discharge, Tooth Abscess, Abdominal Pain Upper, Colitis Microscopic, Chest Pain, Blood Cholesterol Increased, Gastrooesophageal Reflux Disease, Haemorrhoids, Musculoskeletal Pain, Drug Hypersensitivity, Dental Caries, Appendix Disorder, Anxiety, Hyperlipidaemia, Diarrhoea, Osteonecrosis of JAW, Sepsis, Hypertension
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Fosamax
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2001-01-29
End date: 2008-03-20
Provera
Administration route: Oral
Start date: 2001-01-01
Alendronate Sodium
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2008-02-12
End date: 2008-01-01
Actonel
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 2008-04-20
End date: 2010-01-01
Possible Provera side effects in female
Reported by a individual with unspecified qualification from United States on 2012-01-10
Patient: female, weighing 67.1 kg (147.7 pounds)
Reactions: Abdominal Pain, Metaplasia, Breast Cancer in Situ, Mammogram Abnormal, Breast Cyst, Uterine Leiomyoma, Biliary Dilatation, Emotional Disorder, Breast Hyperplasia, Melanocytic Naevus, Proctalgia, Muscle Spasms, Back Pain, Breast Cancer, Postoperative Adhesion, Intervertebral Disc Protrusion, Pain in Extremity, Anaemia, Breast Mass, General Physical Health Deterioration, Osteopenia, Breast Calcifications, Micturition Urgency, Paraesthesia, Uterine Prolapse, Cerebral Small Vessel Ischaemic Disease, Dilatation Intrahepatic Duct Acquired, Insomnia, Osteoporosis, Pain, Rectal Haemorrhage, Breast Induration, Oral Herpes, Fall, Fibrocystic Breast Disease, Fibroadenoma of Breast, Aortic Arteriosclerosis, Intervertebral Disc Degeneration, Injury, Sinusitis, RIB Fracture, Breast Disorder, Biopsy Breast, Avulsion Fracture, Deformity, Anxiety, Atrophic Vulvovaginitis, Oral Pain, Presyncope, Spinal Disorder, Lymph Nodes Scan Abnormal, Arthritis
Drug(s) suspected as cause:
Hormones
Indication: Menopause
Start date: 1988-01-01
End date: 1989-01-01
Provera
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1991-08-18
End date: 1995-08-29
Prempro
Dosage: .625/2.5 mg
Administration route: Oral
Indication: Menopause
Start date: 1995-05-01
End date: 1999-01-12
Premarin
Dosage: 0.9 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1991-05-08
End date: 1991-05-15
Premarin
Dosage: 0.625 mg, unk
Administration route: Oral
Start date: 1991-05-16
End date: 1995-08-29
Estraderm
Dosage: 0.1 (units not spec.) 2x weekly
Indication: Menopause
Start date: 1991-08-18
End date: 1991-10-01
Other drugs received by patient: Anusol HC; H2 Blocker ^ratiopharm^
Possible Provera side effects in female
Reported by a physician from United States on 2011-12-01
Patient: female, weighing 68.0 kg (149.6 pounds)
Reactions: Foot Deformity, Abdominal Pain, Endometrial Hyperplasia, Aortic Stenosis, Chronic Obstructive Pulmonary Disease, Vitamin B12 Deficiency, Dyspepsia, Uterine Leiomyoma, Breast Hyperplasia, Metabolic Disorder, Arteriosclerosis, Breast Cancer, Cardiac Murmur, Hiatus Hernia, Ovarian Cyst, Coronary Artery Disease, Breast Mass, Cervical Dysplasia, Insomnia, Pelvic Pain, Fibrocystic Breast Disease, Fatigue, Chest Pain, Liver Function Test Abnormal, Dizziness, Depression, Gastrooesophageal Reflux Disease, Dyspnoea, Nausea, Amnesia, Rectocele, Dysuria, Visual Impairment
Drug(s) suspected as cause:
Premarin
Dosage: 0.625 mg, unk
Indication: Menopause
Start date: 1990-11-26
End date: 2000-11-01
Provera
Dosage: 10 mg, unk
Start date: 1990-11-26
Medroxyprogesterone
Indication: Menopause
Start date: 1991-01-01
Provera
Dosage: 2.5 mg, unk
End date: 2000-11-01
Ogen
Provera
Indication: Menopause
Start date: 1988-01-01
End date: 1991-01-01
Premarin
Start date: 1988-01-01
End date: 1991-01-01
Prempro
Provera
Start date: 1991-01-01
Premarin
Administration route: Topical
Indication: Menopause
Start date: 1992-03-11
End date: 1997-11-23
Hormones
Administration route: Topical
Indication: Menopause
Start date: 1991-01-01
Climara
Estraderm
Indication: Menopause
Start date: 1991-01-01
End date: 1993-03-11
Estraderm
Dosage: 0.05 mg, biw
Start date: 1992-03-11
End date: 1993-03-11
Cycrin
Dosage: 2.5 mg, unk
Indication: Menopause
Start date: 1997-11-17
End date: 1997-12-17
Other drugs received by patient: Calcium Carbonate; Fosamax; Plavix; Prednisone TAB; Tamoxifen Citrate; Zantac; Magnesium Sulfate; Tricor; Methotrexate; Fluconazole; Paxil; Naproxen (Aleve); Aspirin; Prevacid; Macrodantin; Folic Acid; Zoloft
Possible Provera side effects in female
Reported by a individual with unspecified qualification from United States on 2011-12-01
Patient: female, weighing 61.2 kg (134.7 pounds)
Reactions: Abdominal Pain, Muscle Atrophy, Breast Cancer in Situ, Loss of Consciousness, Breast Cancer Recurrent, Metastasis, Dyspepsia, Vulvovaginal Dryness, Mammogram, Breast Hyperplasia, Back Pain, Dyspareunia, Intervertebral Disc Protrusion, Dysphagia, Oestrogen Receptor Assay Negative, Breast Cancer Stage I, Ovarian Cyst, Breast Cancer Stage III, Breast Mass, Renal Cyst, Osteopenia, Colitis, Breast Necrosis, Excessive Granulation Tissue, Confusional State, Application Site Reaction, Head Injury, Osteoporosis, Pain, Fall, Weight Increased, Fibrocystic Breast Disease, Chest Pain, Intervertebral Disc Degeneration, Injury, Oestrogen Receptor Assay Positive, Depression, Hallucination, Gastrooesophageal Reflux Disease, Progesterone Receptor Assay Negative, Scoliosis, Bone Giant Cell Tumour, Radius Fracture, Anxiety, Atrophic Vulvovaginitis, Spinal Osteoarthritis, Arthritis, Physical Disability, Breast Fibrosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Premarin
Dosage: 0.625 mg, unk
Administration route: Oral
Start date: 1992-10-01
End date: 1997-07-01
Provera
Dosage: 5/2.5 mg day 1-14
Administration route: Oral
Start date: 1992-10-01
End date: 1997-07-01
Ogen
Start date: 1992-06-01
End date: 1993-04-01
Estraderm
Dosage: 0.05 mg, 2x/wk
Start date: 1995-09-01
End date: 1995-11-01
Prempro
Dosage: 625/2.5 mg
Indication: Menopausal Symptoms
Start date: 1996-06-01
End date: 1996-06-01
Premarin
Other drugs received by patient: Multivitamins, Combinations; Xanax; Prozac; Evista
Possible Provera side effects in female
Reported by a lawyer from United States on 2011-11-29
Patient: female, weighing 68.0 kg (149.6 pounds)
Reactions: Abdominal Pain, Aortic Stenosis, Pelvic Pain, Chronic Obstructive Pulmonary Disease, Fatigue, Fibrocystic Breast Disease, Dyspepsia, Uterine Leiomyoma, Chest Pain, Liver Function Test Abnormal, Dizziness, Breast Hyperplasia, Depression, Arteriosclerosis, Breast Cancer, Cardiac Murmur, Hiatus Hernia, Nausea, Breast Mass, Ovarian Cyst, Cervical Dysplasia, Amnesia, Rectocele, Visual Impairment
Drug(s) suspected as cause:
Provera
Dosage: 10 mg, unk
Start date: 1990-11-26
Cycrin
Dosage: 2.5 mg, unk
Indication: Menopause
Start date: 1997-11-17
End date: 1997-12-17
Prempro
Hormones
Administration route: Topical
Indication: Menopause
Start date: 1991-01-01
Ogen
Provera
Start date: 1991-01-01
Premarin
Dosage: 0.625 mg, unk
Indication: Menopause
Start date: 1990-11-26
End date: 2000-11-01
Premarin
Administration route: Topical
Indication: Menopause
Start date: 1992-03-11
End date: 1997-11-23
Estraderm
Dosage: 0.05 mg, biw
Start date: 1992-03-11
End date: 1993-03-11
Premarin
Start date: 1988-01-01
End date: 1991-01-01
Medroxyprogesterone
Indication: Menopause
Start date: 1991-01-01
Provera
Indication: Menopause
Start date: 1988-01-01
End date: 1991-01-01
Provera
Dosage: 2.5 mg, unk
End date: 2000-11-01
Climara
Estraderm
Indication: Menopause
Start date: 1991-01-01
End date: 1993-03-11
Other drugs received by patient: Methotrexate; Aspirin; Naproxen (Aleve); Magnesium Sulfate; Plavix; Macrodantin; Tamoxifen Citrate; Zantac; Prevacid; Fluconazole; Paxil; Prednisone; Folic Acid; Zoloft; Calcium Carbonate; Fosamax; Tricor
Possible Provera side effects in female
Reported by a lawyer from United States on 2011-11-28
Patient: female, weighing 59.0 kg (129.7 pounds)
Reactions: Abdominal Pain, Pulmonary Hypertension, Lymphocyte Count Increased, FAT Embolism, Myocardial Ischaemia, Endoscopy Upper Gastrointestinal Tract, Chronic Obstructive Pulmonary Disease, Lumbar Spinal Stenosis, Metastatic Lymphoma, Hypoxia, Back Pain, Pain in Extremity, Breast Cancer Stage I, Breast Mass, Renal Cyst, Osteopenia, Hepatic Steatosis, Breast Cancer Stage II, Bone Densitometry, Breast Necrosis, Ultrasound Abdomen Abnormal, Pleural Fibrosis, Dyslipidaemia, Osteoporosis, Aortic Aneurysm, Gastritis, Dyspnoea Exertional, Interstitial Lung Disease, Basal Cell Carcinoma, Blood Cholesterol Increased, Malignant Melanoma, Oestrogen Receptor Assay Positive, Myocardial Infarction, Emphysema, Scoliosis, Dyspnoea, Nausea, Squamous Cell Carcinoma, Spondylolisthesis, Peripheral Vascular Disorder, Progesterone Receptor Assay Positive, Pulmonary Fibrosis, Osteoarthritis, Cardiac Failure, Nuclear Magnetic Resonance Imaging Abnormal, Spinal Osteoarthritis, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Medroxyprogesterone
Indication: Hormone Replacement Therapy
Start date: 1997-01-01
End date: 2002-01-01
Prempro
Dosage: .625/2.5 mg
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 1998-12-01
End date: 2002-10-01
Estraderm
Dosage: 0.05 mg, unk
Indication: Osteoporosis Prophylaxis
Start date: 1992-01-01
End date: 1998-12-01
Provera
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Osteoporosis Prophylaxis
Start date: 1992-01-01
End date: 1998-12-01
Other drugs received by patient: Letairis; Calcium; Coumadin; Zocor; Advair Diskus 100 / 50; Boniva; Hydrochlorothiazide; Cozaar; Vitamin D; Spiriva; Celebrex; Viagra; Fosamax
Possible Provera side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-24
Patient: female, weighing 68.0 kg (149.7 pounds)
Reactions: Abdominal Pain, Lymphadenopathy, Metastases To Liver, Headache, Malaise, Hot Flush, Uterine Leiomyoma, Pneumothorax, Hypoxia, Hepatic Cirrhosis, Muscle Spasms, Back Pain, Intervertebral Disc Protrusion, Pneumonia, Ovarian Cyst, Musculoskeletal Discomfort, Osteopenia, Breast Calcifications, Diverticulum Intestinal, Breast Cancer Stage II, Insomnia, Dermal Cyst, Breast Necrosis, Portal Hypertension, General Physical Condition Abnormal, Impaired Work Ability, Pain, Bone Pain, Pelvic Pain, Pleural Effusion, Depression, Cholecystitis, Splenomegaly, Adrenal Mass, Blood Pressure Increased, Polyp, Dyspnoea, Lung Neoplasm, Rash, Deformity, Ascites, Osteoarthritis, Anxiety, Device Failure, Atrophic Vulvovaginitis, Arthralgia, Leukocytosis
Drug(s) suspected as cause:
Estraderm
Dosage: .05 mg, qw2
Indication: Menopause
Start date: 1999-01-01
End date: 2000-01-01
Premarin
Indication: Hormone Replacement Therapy
Cycrin
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1999-01-01
End date: 2000-01-01
Estrostep
Dosage: unk
Indication: Menopause
End date: 2001-01-01
Prempro
Dosage: .625/2.5 mg
Administration route: Oral
Indication: Menopause
Start date: 2000-01-01
End date: 2002-01-01
Medroxyprogesterone Acetate
Indication: Menopause
Provera
Indication: Hormone Replacement Therapy
|